Aroa Biosurgery Limited (ASX:ARX)
Australia · Delayed Price · Currency is AUD 0.6750
0.00 (0.00%)
Jun 3, 2026, 4:10 PM AEST
Aroa Biosurgery Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Aroa Biosurgery stock has a consensus rating of "Strong Buy" and an average price target of $1.08. The average 1-year stock price forecast is 60.00% higher than the current stock price, while the lowest is $0.79 (+17.04%) and the highest is $1.36 (+101.48%).
Price Target: $1.08 (+60.00%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Aroa Biosurgery stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgans | Morgans | Buy Maintains $0.77 | Buy | Maintains | $0.77 | +14.07% | May 5, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $1.16 → $1.35 | Buy | Maintains | $1.16 → $1.35 | +100.00% | May 3, 2026 |
| Bell Potter | Bell Potter | Buy Maintains $1.12 | Buy | Maintains | $1.12 | +65.93% | May 1, 2026 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.